Company Overview and News

0
Adani Transmission rises 3% on LoI for transmission project in Uttar Pradesh

2018-06-14 moneycontrol
Shares of Adani Transmission rose more than 3 percent in the opening trade on Thursday as company received LoI intra state transmission project in Uttar Pradesh.
539254 532955 RECLTD ADANITRANS

0
REC commits $1 mn to International Solar Alliance

2018-06-04 moneycontrol
State-run power sector financier Rural Electrification Corporation (REC) today announced its commitment of USD 1 million to International Solar Alliance (ISA). "In view of the World Environment Day 2018, REC contributed USD one million to the International Solar Alliance (ISA) becoming a corpus contributor," an REC statement said.
532955 RECLTD

21
Market Live: Sensex dips 200 pts amid weak rupee; MM rallies on Q4 earnings

2018-05-29 moneycontrol
Earnings Reaction: Godfrey Phillips India's March quarter profit dropped 22.8 percent year-on-year to Rs 43.1 crore and revenue from operations declined 37.6 percent to Rs 543.3 crore.
500325 RELIANCE 532955 532712 STAR RCOM RIGD GODFRYPHLP HDFCBANK RLNIY BANKINDIA IBN 538835 DCMSRMIND 532941 532149 BHEL 539207 532531 ICICIBANK CORDSCABLE HDB 532174 500180 BRHTY INTELLECT 500103 RECLTD 500163 523369 MANPASAND

23
Market Live: Sensex falls 100 pts, rupee slips 50 paise; BHEL up 9% on Q4 nos

2018-05-29 moneycontrol
Earnings: M&M's March quarter earnings beat analyst expectations as profit grew by 50 percent year-on-year to Rs 1,155 crore and revenue increased 25.6 percent to Rs 13,189 crore during the quarter.
500325 AUROPHARMA RELIANCE 532955 532712 533106 STAR RCOM OIL RIGD HDFCBANK RLNIY BANKINDIA 524804 IBN 538835 532941 532149 BHEL 539207 532531 ICICIBANK CORDSCABLE HDB 532174 500180 ARBQY BRHTY INTELLECT 500103 RECLTD MANPASAND

23
Market Live: Sensex rangebound, PSU Bank index loses 2%; BHEL up 9% on Q4 nos

2018-05-29 moneycontrol
Market Update: Benchmark indices as well as broader markets are in a consolidation mode after sharp rally seen in previous three consecutive sessions. Investors closely monitor the movement in crude oil prices and rupee.
500325 AUROPHARMA RELIANCE 532955 532712 533106 STAR RCOM OIL RIGD 519183 GREENPLY HDFCBANK RLNIY IPCALAB 524804 IBN 538835 BHEL 539207 532531 ICICIBANK 524494 HDB 532174 500180 ARBQY 526797 BRHTY INTELLECT 500103 RECLTD MANPASAND ADFFOODS

20
Market Live: Nifty reclaims 10,700 amid weaker rupee; Vista Pharma up 10%

2018-05-29 moneycontrol
Market Update: The market continued to consolidate after rallying sharply in previous three consecutive sessions. Investors keenly monitor the movement in crude oil prices and rupee.
500325 AUROPHARMA RELIANCE 532955 532712 533106 RCOM OIL RIGD 519183 GREENPLY HDFCBANK RLNIY IPCALAB 524804 IBN 539207 ICICIBANK 524494 HDB 532174 500180 ARBQY 526797 RECLTD MANPASAND ADFFOODS

10
Market Live: Sensex, Nifty consolidate after 3-day rally; weaker rupee lifts IT stocks

2018-05-29 moneycontrol
Buzzing: After being locked in lower circuit on Monday, shares of Manpasand Beverages continued to be locked in the same band today as well, as investors continued to be wary of corporate developments. This is despite the company trying to allay fears around the controversy surrounding its auditor, Deloitte, resigning abruptly.
IPCALAB AUROPHARMA 524804 532955 532712 539207 533106 RCOM 524494 OIL HDB 500180 ARBQY 519183 526797 GREENPLY HDFCBANK RECLTD MANPASAND ADFFOODS

0
REC Q4 net profit down 37% on higher provisions

2018-05-28 moneycontrol
Rural Electrification Corporation (REC) on Monday reported a 37 percent decrease YOY in its March quarter net profit at Rs 834.79 crore, missing estimates due to an increase in provisions for bad loans.
532955 RECLTD

7
ICICI-led group to sell Essar Power arm to recover dues

2018-05-27 freepressjournal.in
Mumbai : An ICICI Bank-led consortium, which includes Rural Electrification Corp, Power Finance Corp, Punjab National Bank and IDFC, is looking to sell Essar Power MP, to recover Rs 6,600 crore of dues, sources said.
PFC PWQFY ICICIBANK PNJZY 532461 532174 IBN PNB 532955 RECLTD 532810

10
4 years of Modi govt, but no achche din for PSU stocks

2018-05-25 thehindubusinessline
Under four years of Modi government, public sector companies, led by banks, have suffered the most. The Nifty PSU Bank index is undoubtedly the biggest loser with negative returns of 24 per cent over the last four years, thanks to lack of meaningful resolution of non-performing assets (NPAs). Analysts have pointed out that the government’s inability to solve the NPA issue has been one of the biggest misses despite the bankruptcy code and recapitalisation.
PWQFY 532955 532810 533278 BHEL PFC 533106 OIL GAILY BRHTY 500103 GAILF RECLTD CLNDY COALINDIA

46
World’s Largest ID Database Exposed by Indian Government Errors - Bloomberg

2018-05-15 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
BC94 SMSN MSFT 532955 RECLTD SMSD

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...